2025
Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis
Sumsuzzman D, Ye Y, Wang Z, Pandey A, Langley J, Galvani A, Moghadas S. Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis. BMC Infectious Diseases 2025, 25: 215. PMID: 39948450, PMCID: PMC11827239, DOI: 10.1186/s12879-025-10610-5.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsAgedComorbidityCOVID-19COVID-19 VaccinesFemaleHumansMaleSARS-CoV-2Severity of Illness IndexSex FactorsVaccinationConceptsPopulation settingEffective public health strategiesConfidence intervalsImpact of disease severityModified Newcastle-Ottawa ScalePublic health strategiesHigher secondary attack rateRisk of biasNewcastle-Ottawa ScalePandemic responseGlobal systematic reviewRandom-effects modelFreeman-Tukey double arcsine transformationWeb of ScienceNo significant associationDrivers of SARS-CoV-2 transmissionHealth strategiesSecondary attack rateSARS-CoV-2Disease severityEffective pandemic responseTargeted interventionsDouble arcsine transformationOvid MEDLINESystematic reviewImproving entity recognition using ensembles of deep learning and fine-tuned large language models: A case study on adverse event extraction from VAERS and social media
Li Y, Viswaroopan D, He W, Li J, Zuo X, Xu H, Tao C. Improving entity recognition using ensembles of deep learning and fine-tuned large language models: A case study on adverse event extraction from VAERS and social media. Journal Of Biomedical Informatics 2025, 163: 104789. PMID: 39923968, DOI: 10.1016/j.jbi.2025.104789.Peer-Reviewed Original ResearchConceptsTraditional deep learning modelsDeep learning modelsRecurrent neural networkLearning modelsEntity recognitionLanguage modelF1 scoreEnsemble of deep learningAdvances of natural language processingEffectiveness of ensemble methodsMicro-averaged F1Bidirectional Encoder RepresentationsExtensive labeled dataNatural language processingFine-tuned modelsBiomedical text miningFeature representationEncoder RepresentationsEvent extractionEntity typesText dataDeep learningSequential dataGPT-2Neural networkEffectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation.
Ioannou G, Berry K, Rajeevan N, Li Y, Yan L, Huang Y, Lin H, Bui D, Hynes D, Rowneki M, Bohnert A, Boyko E, Iwashyna T, Maciejewski M, Smith V, Berkowitz T, O'Hare A, Viglianti E, Aslan M, Bajema K. Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation. Annals Of Internal Medicine 2025, 178: 348-359. PMID: 39903865, DOI: 10.7326/annals-24-01015.Peer-Reviewed Original ResearchMeSH KeywordsAgedCOVID-19COVID-19 VaccinesFemaleFollow-Up StudiesHospitalizationHumansMaleMiddle AgedSARS-CoV-2United StatesVaccine EfficacyConceptsU.S. Department of Veterans AffairsDepartment of Veterans AffairsMatched index dateVaccine effectivenessTarget trial emulationSARS-CoV-2-associated deathsRandomized controlled trialsCOVID-19 vaccineSARS-CoV-2-related outcomesSARS-CoV-2 testingVeterans AffairsResidual confoundingAbsence of randomized controlled trialsLong-term follow-upDocumented SARS-CoV-2 infectionTrial emulationUnvaccinated personsIndex datePositive resultsControlled trialsCOVID-19SARS-CoV-2 infectionIncomplete captureHospitalDocumented infection
2024
Machine learning-enhanced immunopeptidomics applied to T-cell epitope discovery for COVID-19 vaccines
Kovalchik K, Hamelin D, Kubiniok P, Bourdin B, Mostefai F, Poujol R, Paré B, Simpson S, Sidney J, Bonneil É, Courcelles M, Saini S, Shahbazy M, Kapoor S, Rajesh V, Weitzen M, Grenier J, Gharsallaoui B, Maréchal L, Wu Z, Savoie C, Sette A, Thibault P, Sirois I, Smith M, Decaluwe H, Hussin J, Lavallée-Adam M, Caron E. Machine learning-enhanced immunopeptidomics applied to T-cell epitope discovery for COVID-19 vaccines. Nature Communications 2024, 15: 10316. PMID: 39609459, PMCID: PMC11604954, DOI: 10.1038/s41467-024-54734-9.Peer-Reviewed Original ResearchConceptsT cell epitopesT cellsCD8+ T cell epitopesT cell immunityT cell epitope discoverySARS-CoV-2T-cell-directed vaccinationDesigning effective vaccinesB7 supertypePatient's proteomesSARS-CoV-2 variantsVaccine epitopesViral antigensSpike antigenVaccine developmentEffective vaccineEpitope discoveryCOVID-19 vaccineVaccineEpitopesAntigenic featuresOmicron variantAntigenCOVID-19CD8Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, November 2024
Reses H, Segovia G, Dubendris H, Barbre K, Ananth S, Lape-Newman B, Wong E, Stillions M, Rowe T, Mothershed E, Wallender E, Twentyman E, Wiegand R, Patel P, Benin A, Bell J. Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, November 2024. MMWR Morbidity And Mortality Weekly Report 2024, 73: 1052-1057. PMID: 39570790, PMCID: PMC11581205, DOI: 10.15585/mmwr.mm7346a2.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusRespiratory syncytial virus vaccineNational Healthcare Safety NetworkSyncytial virusVaccination coverageSusceptible to severe outcomesHealth and Human Services regionsRespiratory virus seasonCOVID-19 vaccineCDC's National Healthcare Safety NetworkInfluenza vaccineVirus seasonSevere complicationsRespiratory virusesAssociated with respiratory illnessInfluenzaNursing home residentsSafety NetworkRespiratory illnessSevere outcomesReport vaccinationElevated riskSARS-CoV-2VaccineIndex levelsEffectiveness of Original Monovalent and Bivalent COVID‐19 Vaccines Against COVID‐19‐Associated Hospitalization and Severe In‐Hospital Outcomes Among Adults in the United States, September 2022–August 2023
DeCuir J, Surie D, Zhu Y, Lauring A, Gaglani M, McNeal T, Ghamande S, Peltan I, Brown S, Ginde A, Steinwand A, Mohr N, Gibbs K, Hager D, Ali H, Frosch A, Gong M, Mohamed A, Johnson N, Srinivasan V, Steingrub J, Khan A, Busse L, Duggal A, Wilson J, Qadir N, Chang S, Mallow C, Kwon J, Exline M, Shapiro N, Columbus C, Vaughn I, Ramesh M, Safdar B, Mosier J, Casey J, Talbot H, Rice T, Halasa N, Chappell J, Grijalva C, Baughman A, Womack K, Rhoads J, Swan S, Johnson C, Lewis N, Ellington S, Dawood F, McMorrow M, Self W, Network F. Effectiveness of Original Monovalent and Bivalent COVID‐19 Vaccines Against COVID‐19‐Associated Hospitalization and Severe In‐Hospital Outcomes Among Adults in the United States, September 2022–August 2023. Influenza And Other Respiratory Viruses 2024, 18: e70027. PMID: 39496339, PMCID: PMC11534416, DOI: 10.1111/irv.70027.Peer-Reviewed Original ResearchConceptsCOVID-19-associated hospitalizationIn-hospital outcomesVaccine effectivenessMonovalent dosesAbsolute VETest-negative case-control designInvasive mechanical ventilationCOVID-19 vaccineMultivariate logistic regressionSevere COVID-19Case patientsCase-control designControl patientsMechanical ventilationUnvaccinated patientsPatientsMonovalent vaccineCOVID-19-like illnessDoseCOVID-19 vaccine effectivenessBivalent vaccineLogistic regressionAdmission dateVaccineHospitalInfluenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season
Bell J, Meng L, Barbre K, Wong E, Lape-Newman B, Koech W, Soe M, Woods A, Kuhar D, Stuckey M, Dubendris H, Rowe T, Lindley M, Kalayil E, Edwards J, Benin A, Reses H. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season. MMWR Morbidity And Mortality Weekly Report 2024, 73: 966-972. PMID: 39480706, PMCID: PMC11527362, DOI: 10.15585/mmwr.mm7343a2.Peer-Reviewed Original ResearchConceptsAcute care hospitalsHealth care personnelNational Healthcare Safety NetworkVaccination of health care personnelNursing homesCare personnelCare hospitalU.S. health care settingsHealth care settingsRespiratory virus seasonSafety NetworkHealth care facilitiesVaccination coverageCOVID-19 vaccination coverageCDC's National Healthcare Safety NetworkInfluenza vaccination coverageCare settingsVirus seasonCare facilitiesNursesHealthy workforceCOVID-19 vaccineAnnual influenza vaccinationCOVID-19HealthDevelopment of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients–March 2022—April 2023
Bui D, Bajema K, Huang Y, Yan L, Li Y, Rajeevan N, Berry K, Rowneki M, Argraves S, Hynes D, Huang G, Aslan M, Ioannou G. Development of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients–March 2022—April 2023. PLOS ONE 2024, 19: e0307235. PMID: 39365775, PMCID: PMC11451987, DOI: 10.1371/journal.pone.0307235.Peer-Reviewed Original ResearchConceptsVeterans Health AdministrationCOVID-19 hospitalizationArea under the receiver operating characteristic curveComprehensive electronic health recordNational cohortElectronic health recordsAll-cause mortalityNational cohort of patientsFull modelHealth recordsHealth AdministrationReceipt of COVID-19 vaccineMortality riskEpidemiology of COVID-19COVID-19High-risk patientsBrier scoreCohort of patientsAnti-SARS-CoV-2 treatmentCOVID-19 vaccineReceiver operating characteristic curveCalibration interceptHospitalAntiviral treatmentAvailability of effective vaccinesThe next Nobel Prize in chemistry or in physiology or medicine
Kadoch C, Sheltzer J, Yin H. The next Nobel Prize in chemistry or in physiology or medicine. Cell Chemical Biology 2024, 31: 1566-1567. PMID: 39303696, DOI: 10.1016/j.chembiol.2024.08.013.Peer-Reviewed Original ResearchGlobal pandemic preparedness: learning from the COVID-19 vaccine development and distribution
Agampodi S, Mogeni O, Chandler R, Pansuriya M, Kim J, Excler J. Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution. Expert Review Of Vaccines 2024, 23: 761-772. PMID: 39167221, DOI: 10.1080/14760584.2024.2395546.Peer-Reviewed Original ResearchMeSH KeywordsCOVID-19COVID-19 VaccinesDeveloping CountriesGlobal HealthHumansPandemicsSARS-CoV-2Vaccine DevelopmentConceptsPandemic vaccine developmentVaccine developmentGlobal health securityField of vaccinologyVaccine deliveryFuture pandemicsTherapeutic agentsVaccineHealth securityCOVID-19 vaccine developmentResponse frameworkPandemic preparednessDistribution of vaccinesStakeholder websitesCOVID-19Adequate fundingVaccine innovationCOVID-19 pandemicExploring the Big Data Paradox for various estimands using vaccination data from the global COVID-19 Trends and Impact Survey (CTIS)
Yang Y, Dempsey W, Han P, Deshmukh Y, Richardson S, Tom B, Mukherjee B. Exploring the Big Data Paradox for various estimands using vaccination data from the global COVID-19 Trends and Impact Survey (CTIS). Science Advances 2024, 10: eadj0266. PMID: 38820165, PMCID: PMC11314312, DOI: 10.1126/sciadv.adj0266.Peer-Reviewed Original ResearchMeSH KeywordsAdultBig DataCOVID-19COVID-19 VaccinesFemaleHumansIndiaMaleMiddle AgedSARS-CoV-2Surveys and QuestionnairesVaccinationPost-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection
Malden D, Liu I, Qian L, Sy L, Lewin B, Asamura D, Ryan D, Bezi C, Williams J, Kaiser R, Daley M, Nelson J, McClure D, Zerbo O, Henninger M, Fuller C, Weintraub E, Saydah S, Tartof S. Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection. Nature Communications 2024, 15: 4101. PMID: 38778026, PMCID: PMC11111703, DOI: 10.1038/s41467-024-48022-9.Peer-Reviewed Original ResearchConceptsElectronic health recordsPost-COVID conditionsMatched cohort studyRetrospective matched cohort studyRelative riskCohort studyAdjusted relative risksSARS-CoV-2 positive testAssociated with reduced riskMental health disordersPositive SARS-CoV-2 testLow riskLong-term consequences of COVID-19Health recordsSARS-CoV-2 testingPoisson regressionHealth disordersHealthcare systemCOVID-19SARS-CoV-2 infectionConsequences of COVID-19Younger ageCOVID-19 casesSARS-CoV-2Long-term consequencesEvaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon
Nour D, Ismail M, Osman M, Rafei R, Kasir D, Dabboussi F, Colson P, Hamze M. Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon. PLOS ONE 2024, 19: e0302579. PMID: 38722969, PMCID: PMC11081361, DOI: 10.1371/journal.pone.0302579.Peer-Reviewed Original ResearchConceptsImmune responseAntibody titersAntibody levelsAnti-spike antibody levelsCharacteristics of immune responsesWaning immune responsesMultivariate logistic regression modelSARS-CoV-2 antibody titersLevel of antibody titerVaccinated patientsBNT162b2 vaccineUnivariate analysisLogistic regression modelsSputnik V vaccineBlood specimensPfizer-BioNTechVaccine doseImmune statusVaccinated adultsSARS-CoV-2InfectionNorth LebanonVaccineAstraZeneca vaccineTitersInformation processing style and institutional trust as factors of COVID vaccine hesitancy
Zhao W, Russell C, Jankovsky A, Cannon T, Pittenger C, Pushkarskaya H. Information processing style and institutional trust as factors of COVID vaccine hesitancy. Scientific Reports 2024, 14: 10416. PMID: 38710827, PMCID: PMC11074285, DOI: 10.1038/s41598-024-60788-y.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCOVID-19COVID-19 VaccinesFemaleHumansMaleMiddle AgedPublic HealthSARS-CoV-2TrustVaccinationVaccination HesitancyYoung AdultConceptsInformation processing styleIndividual cognitive styleProcessing styleCognitive styleSelf-report measures of personalityMeasures of personalitySelf-report measuresInformation processing capacityPersonality traitsBehavioral tasksStructural equation modelingAuthoritarian submissionEquation modelingProcessing capacityStylePersonsComprehensive assessmentInformation processing capabilitiesPerceptionTrust levelProcessing capabilitiesMultifactorial natureSocio-demographic factorsClinical characteristicsTaskPredicting clinical outcomes of SARS-CoV-2 infection during the Omicron wave using machine learning
Cogill S, Nallamshetty S, Fullenkamp N, Heberer K, Lynch J, Lee K, Aslan M, Shih M, Lee J. Predicting clinical outcomes of SARS-CoV-2 infection during the Omicron wave using machine learning. PLOS ONE 2024, 19: e0290221. PMID: 38662748, PMCID: PMC11045098, DOI: 10.1371/journal.pone.0290221.Peer-Reviewed Original ResearchConceptsHigh-risk groupSARS-CoV-2 infectionAnticoagulant useAdverse outcomesPredictor of adverse outcomesHigher risk of adverse outcomesLower body mass indexRisk of adverse outcomesVaccination of high-risk groupsOral anticoagulant useOutcome of SARS-CoV-2 infectionRetrospective longitudinal observational studySARS-CoV-2U.S. Veterans Health AdministrationClinical outcomes of SARS-CoV-2 infectionIdentification of patientsBody mass indexVeterans Health AdministrationPredictors of hospitalizationEscalation of careLongitudinal observational studyClinical outcomesOmicron SARS-CoV-2 variantSARS-CoV-2 variantsUnvaccinated patientsCOVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19–Associated Hospitalization Among Residents in Nursing Homes — National Healthcare Safety Network, United States, October 2023–February 2024
Franklin D, Barbre K, Rowe T, Reses H, Massey J, Meng L, Dollard P, Dubendris H, Stillions M, Robinson L, Clerville J, Slifka K, Benin A, Bell J. COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19–Associated Hospitalization Among Residents in Nursing Homes — National Healthcare Safety Network, United States, October 2023–February 2024. MMWR Morbidity And Mortality Weekly Report 2024, 73: 339-344. PMID: 38635474, PMCID: PMC11037435, DOI: 10.15585/mmwr.mm7315a3.Peer-Reviewed Original ResearchMeSH KeywordsCOVID-19COVID-19 VaccinesHospitalizationHumansNursing HomesSARS-CoV-2United StatesVaccinationVaccination CoverageConceptsNursing home residentsNational Healthcare Safety NetworkHome residentsPercentage of facilitiesCOVID-19-associated hospitalizationRates of SARS-CoV-2 infectionSARS-CoV-2 infectionRespiratory virus seasonIncident SARS-CoV-2 infectionProtect nursing home residentsCOVID-19 vaccination coverageWeekly percentageEvidence-based interventionsVaccination coverageEvaluate evidence-based interventionsFacility-level dataSafety NetworkVirus seasonCDC's National Healthcare Safety NetworkWeekly rateSARS-CoV-2Nursing homesNursesCOVID-19Severe COVID-19IL-1 receptor 1 signaling shapes the development of viral antigen-specific CD4+ T cell responses following COVID-19 mRNA vaccination
Park H, Shin M, Shin J, Kim H, Kang B, Par-Young J, Unlu S, Afinogenova Y, Catanzaro J, Young J, Kim M, Lee S, Jeon S, You S, Racke M, Bucala R, Kang I. IL-1 receptor 1 signaling shapes the development of viral antigen-specific CD4+ T cell responses following COVID-19 mRNA vaccination. EBioMedicine 2024, 103: 105114. PMID: 38640835, PMCID: PMC11041015, DOI: 10.1016/j.ebiom.2024.105114.Peer-Reviewed Original ResearchConceptsCD4<sup>+</sup> T cellsCOVID-19 mRNA vaccinesAntigen-specific CD4<sup>+</sup> T cell responsesT cell responsesPrimary antibody deficiencyCD4<sup>+</sup> T cell responsesT cellsIL-1R1MRNA vaccinesIL-1IgG antibodiesAntigen-specific CD4<sup>+</sup> T cellsCD4+ T cell responsesLevels of IL-1R1Human CD4<sup>+</sup> T cellsIL-1 receptor 1Healthy individualsDose of COVID-19 mRNA vaccineAntigen-specific CD4IL-1R1 expressionT cell immunityRepetitive antigenic stimulationCytokines interleukin (IL)-1Immune response to virusesExpression of IL-1R1Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination
Vesco K, Denoble A, Lipkind H, Kharbanda E, DeSilva M, Daley M, Getahun D, Zerbo O, Naleway A, Jackson L, Williams J, Boyce T, Fuller C, Weintraub E, Vazquez-Benitez G. Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination. Obstetrics And Gynecology 2024, 143: 794-802. PMID: 38626447, PMCID: PMC11090513, DOI: 10.1097/aog.0000000000005583.Peer-Reviewed Original ResearchConceptsSmall-for-gestational ageMessenger RNA COVID-19 vaccineGestational diabetes mellitusRisk of adverse pregnancy outcomesAdverse pregnancy outcomesPreterm birthGestational hypertensionAdjusted hazard ratiosCOVID-19 vaccine dosesPregnancy outcomesCOVID-19 vaccineAssociated with small-for-gestational ageIncreased risk of adverse pregnancy outcomesVaccine doseRisk of preterm birthMessenger RNARetrospective cohort study of individualsMRNA COVID-19 vaccineWeeks of gestationRetrospective cohort studyHistory of COVID-19Cohort study of individualsVaccine Safety DatalinkSingleton pregnanciesUnexposed pregnanciesCOVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report
McDonnell J, Cousins K, Younger M, Lane A, Abolhassani H, Abraham R, Al-Tamemi S, Aldave-Becerra J, Al-Faris E, Alfaro-Murillo A, AlKhater S, Alsaati N, Doss A, Anderson M, Angarola E, Ariue B, Arnold D, Assa’ad A, Aytekin C, Bank M, Bergerson J, Bleesing J, Boesing J, Bouso C, Brodszki N, Cabanillas D, Cady C, Callahan M, Caorsi R, Carbone J, Carrabba M, Castagnoli R, Catanzaro J, Chan S, Chandra S, Chapdelaine H, Chavoshzadeh Z, Chong H, Connors L, Consonni F, Correa-Jimenez O, Cunningham-Rundles C, D’Astous-Gauthier K, Delmonte O, Demirdag Y, Deshpande D, Diaz-Cabrera N, Dimitriades V, El-Owaidy R, ElGhazali G, Al-Hammadi S, Fabio G, Faure A, Feng J, Fernandez J, Fill L, Franco G, Frenck R, Fuleihan R, Giardino G, Galant-Swafford J, Gambineri E, Garabedian E, Geerlinks A, Goudouris E, Grecco O, Pan-Hammarström Q, Khani H, Hammarström L, Hartog N, Heimall J, Hernandez-Molina G, Horner C, Hostoffer R, Hristova N, Hsiao K, Ivankovich-Escoto G, Jaber F, Jalil M, Jamee M, Jean T, Jeong S, Jhaveri D, Jordan M, Joshi A, Kalkat A, Kanarek H, Kellner E, Khojah A, Khoury R, Kokron C, Kumar A, Lecerf K, Lehman H, Leiding J, Lesmana H, Lim X, Lopes J, López A, Tarquini L, Lundgren I, Magnusson J, Marinho A, Marseglia G, Martone G, Mechtler A, Mendonca L, Milner J, Mustillo P, Naderi A, Naviglio S, Nell J, Niebur H, Notarangelo L, Oleastro M, Ortega-López M, Patel N, Petrovic G, Pignata C, Porras O, Prince B, Puck J, Qamar N, Rabusin M, Raje N, Regairaz L, Risma K, Ristagno E, Routes J, Roxo-Junior P, Salemi N, Scalchunes C, Schuval S, Seneviratne S, Shankar A, Sherkat R, Shin J, Siddiqi A, Signa S, Sobh A, Lima F, Stenehjem K, Tam J, Tang M, Barros M, Verbsky J, Vergadi E, Voelker D, Volpi S, Wall L, Wang C, Williams K, Wu E, Wu S, Zhou J, Cook A, Sullivan K, Marsh R. COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report. Journal Of Clinical Immunology 2024, 44: 86. PMID: 38578389, PMCID: PMC10997719, DOI: 10.1007/s10875-023-01613-5.Peer-Reviewed Original ResearchConceptsInborn errors of immunityCOVID-19 vaccineICU admissionInborn errors of immunity patientsInborn errorsUS Immunodeficiency NetworkErrors of immunityVaccination prior to infectionLogistic regression analysisVaccine safetyAntibody deficiencyRates of hospitalizationCOVID-19 severitySymptomatic anemiaOdds of hospitalizationCOVID-19 infectionRegistry databaseMRNA-basedCOVID-19 vaccine safetyPatientsOutpatient clinicEmergency room careICU careICUVaccineAttitudes Toward COVID-19 Vaccines Among Pregnant and Recently Pregnant Individuals
Williams J, Kurlandsky K, Breslin K, Durfee M, Stein A, Hurley L, Shoup J, Reifler L, Daley M, Lewin B, Goddard K, Henninger M, Nelson J, Vazquez-Benitez G, Hanson K, Fuller C, Weintraub E, McNeil M, Hambidge S. Attitudes Toward COVID-19 Vaccines Among Pregnant and Recently Pregnant Individuals. JAMA Network Open 2024, 7: e245479. PMID: 38587844, PMCID: PMC11002697, DOI: 10.1001/jamanetworkopen.2024.5479.Peer-Reviewed Original ResearchConceptsVaccine Safety DatalinkHispanic respondentsHigher risk of severe COVID-19 outcomesPregnant peopleNon-Hispanic white respondentsCross-sectional survey studyWave 2Centers for Disease Control and PreventionNon-Hispanic blacksUS Centers for Disease Control and PreventionSpanish-speaking membersHealth care systemVaccination statusDisease Control and PreventionPublic health messagesRisk of severe COVID-19 outcomesControl and PreventionSelf-reported vaccination statusProportion of respondentsPublic health concernSevere COVID-19 outcomesNon-HispanicCare systemHealth messagesMain Outcomes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply